"Alprostadil" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent vasodilator agent that increases peripheral blood flow.
| Descriptor ID |
D000527
|
| MeSH Number(s) |
D10.251.355.255.550.250.100 D10.251.355.325.050 D23.469.050.175.725.250.100
|
| Concept/Terms |
Alprostadil- Alprostadil
- PGE1alpha
- Prostaglandin E1alpha
- PGE1
- Lipo-PGE1
- Lipo PGE1
- Prostaglandin E1
|
Below are MeSH descriptors whose meaning is more general than "Alprostadil".
Below are MeSH descriptors whose meaning is more specific than "Alprostadil".
This graph shows the total number of publications written about "Alprostadil" by people in this website by year, and whether "Alprostadil" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 |
| 1994 | 0 | 1 | 1 |
| 1996 | 2 | 1 | 3 |
| 2007 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Alprostadil" by people in Profiles.
-
Pirman DA, Efuet E, Ding XP, Pan Y, Tan L, Fischer SM, DuBois RN, Yang P. Changes in cancer cell metabolism revealed by direct sample analysis with MALDI mass spectrometry. PLoS One. 2013; 8(4):e61379.
-
Butts RJ, Ellis AR, Bradley SM, Hulsey TC, Atz AM. Effect of prostaglandin duration on outcomes in transposition of the great arteries with intact ventricular septum. Congenit Heart Dis. 2012 Jul-Aug; 7(4):387-91.
-
Cochran JB, Losek JD. Acute liver failure in children. Pediatr Emerg Care. 2007 Feb; 23(2):129-35.
-
D'Armini AM, Lemasters JJ, Egan TM. Studies of rat lung viability and adenine nucleotide metabolism after death. Ann Thorac Surg. 1996 Nov; 62(5):1448-53.
-
Klein AS, Cofer JB, Pruett TL, Thuluvath PJ, McGory R, Uber L, Stevenson WC, Baliga P, Burdick JF. Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial. Gastroenterology. 1996 Sep; 111(3):710-5.
-
Chavin KC, Uber L, Baliga P, Rajagopalan P, Coder JB. The effects of prostaglandin E1 on hepatic allograft vascular inflow: a prospective randomized double-blind study. Am Surg. 1996 Mar; 62(3):184-7.
-
Reinstein LJ, Lichtman SN, Currin RT, Wang J, Thurman RG, Lemasters JJ. Suppression of lipopolysaccharide-stimulated release of tumor necrosis factor by adenosine: evidence for A2 receptors on rat Kupffer cells. Hepatology. 1994 Jun; 19(6):1445-52.
-
Currin RT, Reinstein LJ, Lichtman SN, Thurman RG, Lemasters JJ. Inhibition of tumor necrosis factor release from cultured rat Kupffer cells by agents that reduce graft failure from storage injury. Transplant Proc. 1993 Feb; 25(1 Pt 2):1631-2.
-
Dorman BH, Harvey SC, Conroy JM, Crumbley AJ, Handy JR, Uber WE, Brahen NH. Very high-dose prostaglandin E1 requirement for heart transplantation. J Heart Lung Transplant. 1992 Jul-Aug; 11(4 Pt 1):724-6.
-
Ethier SP, van de Velde RM, Cundiff KC. cAMP levels in proliferating rat mammary epithelial cells in vitro and in vivo. Exp Cell Res. 1989 Jun; 182(2):653-8.